Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Just For You Oklo: The Bottom Is In, and the Upside Potential Is NuclearAuthor: Thomas Hughes. First Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
Oklo Inc. (NYSE: OKLO) faces headwinds — including no revenue or profits — but the market appears unconcerned. The company's fiscal year 2025 (FY2025) progress report and updates show it is on track to meet long-term goals and expectations. The market response, including analyst updates after the release, makes the point: current revenue isn't the focus given the long-term opportunity. Analysts Focus on Oklo's Long-Term Opportunity MarketBeat tracked roughly half a dozen revisions within the first 12 hours after the release. They included one price-target reduction, offset by a larger number of affirmed ratings and targets, and no downgrades. I Met Elon Musk "Face-to-Face" During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally. As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date: March 26, 2026. Circle it on your calendar. I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade. Click Here to See how to Get Your "SpaceX Access Code" The activity reflects a broader trend: expanding coverage, a steady Moderate Buy consensus, a 58% buy-side bias, and an upward drift in price targets. Those targets matter — consensus forecasts imply more than 50% upside versus mid-March lows. Analysts did express concern about the 2025 results, but they remain primarily focused on the long-term opportunity and on progress with Nuclear Regulatory Commission licensing. The company did receive its first license, awarded to its subsidiary Atomic Alchemy, which handles isotopes. The license permits the receiving, possession, storage, processing, repackaging, and distribution of up to two curies of radium-226 — roughly two grams. Two grams isn't much, and radium-226 on its own is not highly valuable. Once commonly used in medicine, it is now a nuisance to handle and remediate. However, demand is rising because radium-226 can be the source material for actinium. Actinium is one of the most expensive elements and is used in specialized cancer treatments that can cost roughly $20,000 per dose. The investor takeaway: Oklo's diversification strategy appears validated, and a revenue stream has been opened. It may take a few quarters for meaningful revenue to flow, but it could come well before the full commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Point to a Bottom for Oklo Stock Institutional and short-selling data suggest Oklo stock may have bottomed. Short interest remains elevated, near 15% as of early March, but it has declined from its peak near the October 2025 highs and will likely continue to fall in upcoming reports. Institutional activity has moved in the opposite direction, ramping up after Oklo's Q2 2025 plunge and reaching record highs in early 2026. Institutions now own roughly 85% of the stock, which provides solid support, and are accumulating at an estimated rate of $3 bought for every $1 sold. If these trends persist, the float available to traders could shrink significantly in the coming months, making price appreciation easier and increasing the potential for a short squeeze if a catalyst emerges. Dilution Headwinds Ease in 2026 Shareholder dilution was a notable issue in 2025 but appears to be waning in 2026. The company's share count is up about 50% year over year, and the balance sheet remains well capitalized. FY2026 plans suggest there is sufficient capital to fund projects at the current burn rate for roughly two years, giving secondary revenue initiatives, like the isotope business, a window to develop. The trade-off is that profitability isn't expected until 2030, so additional capital will likely be required down the road. The technical setup looks constructive. OKLO's stock is well below its highs and appeared oversold in March. The MACD has diverged and turned bullish, and the stochastic oscillator has followed suit, signaling a strong buy at current levels. Whether the market follows through on these indicators may take time, and the lack of current revenue and profits remains a heavy burden for any recovery. The biggest risk is execution and delay. The market is pricing in robust growth — valuing the stock at more than 100x its initial-year earnings — and may be intolerant of significant delays. In that scenario, Oklo could experience notable volatility whether the rebound begins sooner or later. | 
